Compound brief
Evidence brief. Not treatment advice or a safety clearance. Last evidence update: September 2026.
A cationic antimicrobial peptide. At epithelial surfaces it can recruit cells and it can also quiet some inflammatory signals, so one cytokine arrow does not fit. No infection regimen is stored.
An antimicrobial peptide on a screen is not an antibiotic course.
hCAP-18 is cleaved to LL-37 in neutrophils and at epithelial surfaces. The peptide can disrupt microbial membranes.
The same peptide is discussed as both a recruiter of immune cells and a damper of some cytokine programs. The sheet leaves those directions mixed.
Forum themes are unverified. They do not outrank a study, and they are not a dose.
Antimicrobial shortcut · unverified
Forums describe LL-37 as an immune peptide for infections. The chemistry is a cationic fragment of cathelicidin. Those posts are not an antibiotic regimen.
Theme summarized from public discussion. Not a quoted post, not a trial, and not a dose.